X0609 4 2026-08-17 0 0001827635 Veradermics, Inc MANE 0002107508 Durso Timothy August false C/O VERADERMICS, INCORPORATED 470 JAMES ST. NEW HAVEN CT 06513 0 1 0 0 Chief Technical Officer 1 Common Stock 2026-08-17 4 M 0 3452 12.19 A 121642 D Common Stock 2026-08-17 4 S 0 7918 106.71 D 113724 D Common Stock 2026-08-17 4 S 0 16306 107.52 D 97418 D Common Stock 2026-08-17 4 S 0 16767 108.38 D 80651 D Common Stock 2026-08-17 4 S 0 2348 109.34 D 78303 D Common Stock 2026-08-17 4 S 0 161 111.28 D 78142 D Stock Option (Right to Buy) 12.19 2026-08-17 4 M 0 3452 0 D 2026-12-12 Common Stock 3452 0 D The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $106.25 to $106.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $107.00 to $107.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $108.00 to $108.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $109.00 to $109.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. This option is fully vested and exercisable as of the date hereof. /s/ Michael Greco, Attorney-in-Fact 2026-08-18